Pharmaceutical companies have managed their business in much the same way for decades. But significant changes in government regulations, market conditions, and technology will force the industry to look for new business models and practices. Companies that don't adapt face an uncertain and unsettling future.
Saturday, September 26, 2015
DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/n8484d/cns_drug_news)
has announced the addition of the "CNS
Drug News Issue" newsletter to their offering.
Generic competition for the 20mg version of Teva Pharmaceutical
Industries current multiple sclerosis market leader Copaxone will be
available in the US by September. About Altace (Ramipril) with no Rx This, coupled with growing sales of
Biogen s Tecfidera, will see Tecfidera 2015 sales overtake those of
Copaxone.
These days we all suffer from information overload; by focusing
specifically on CNS drugs, the CNS Drug News online service will deliver
the information you need in a timely, flexible and convenient format.
An ageing population and ever better rates of diagnosis is seeing the
incidence of major CNS sectors rise considerably - particularly
demanding are the neurodegenerative conditions. Buy Xylocaine (Lidocaine) with free Rx Even so, levels of unmet
clinical need remain high and growth is expected to continue.
For pharmaceutical company executives, researchers and commercial
managers, staying in touch with the latest twists and turns is another
matter. Buy Levitra Pack-90 () without Rx That is why CNS Drug News is essential.
The CNS Drug News service provides unbeatable coverage:
- The full text daily of the latest news reported on all types of CNS
drugs for leading CNS conditions
- An easy-to-use interface that immediately takes you to the most
recently-updated information
- An extensive archive of articles, which makes the service a valuable
tracking and research tool
- A fast and effective search facility allowing you to identify
information relevant to you
- Daily or weekly email alerts that will ensure you know when new
information is added
- An RSS feed facility
Every day, the researchers and editors
- Track the companies and research organisations that are shaping the
industry
- Monitor results from major conferences and meetings
Report the latest developments in current and up-coming CNS drugs,
including those for:
- Neurodegenerative Disorders
- Sleep Disorders
- Depression
- Psychotic Disorders
- Analgesia/Anaesthetics
- Epilepsy
- Substance Dependence Therapies
- Nausea & Vertigo
- Cerebrovascular Disorders
- Eating Disorders
Key Topics Covered:
1. About Flutinap with no Rx Tecfidera Will Be Leading MS Drug In 2015
2. Buy Imodium (Loperamide) with free prescription Neurodegenerative Disorders
3. Buy Cough online Parkinson s Disease - R&D
4. http://cholesterolreviews.wordpress.com Biotie Provides Update On Tozadenant Phase III Programme
5. R&D
6. R&D
7. GW Receives FDA ODD For CBD For NHIE
8. R&D
9. Follow-Up Announcement Made On Preliminary Findings From Lurasidone
Phase III Study
10. Product Updates
11. R&D
12. Product Updates
For more information visit .researchandmarkets.com/research/n8484d/cns_drug_news
About Research and Markets
Research and Markets is the world s leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
Friday, September 11, 2015
Crohn's Disease - Pipeline Review, H1 2015
. http://asthmareview.wordpress.com DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/l6pzmr/crohns_disease)
has announced the addition of the "Crohn s
Disease - Pipeline Review, H1 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Crohn s Disease, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. About Zyprexa (Olanzapine) without prescription It also
reviews key players involved in the therapeutic development for Crohn s
Disease and special features on late-stage and discontinued projects.
the report features investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000 indications. Buy Avodart (Dutasteride) with no Rx The report is built
using data and information sourced from the proprietary databases,
Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and
industry-specific third party sources, put together by the team. Buy Aceon (Perindopril) without Rx Drug
profiles/records featured in the report undergoes periodic updation
following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Femodene with free Rx Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. About Malegra FXT (Sildenafil/Fluoxetine) It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Companies Mentioned
Partial list of the 70+ companies mentioned in this comprehensive report:
4SC
AB Science
Baliopharm
BIOCAD
Calypso Biotech
Celgene
Daiichi Sankyo
DBV Technologies
Effimune
Eisai
Farmacija d.o.o. Buy Cell Volumizers online Tuzla
Ferring International Center
Galapagos
Genentech
iCo Therapeutics
Idera Pharmaceuticals
Johnson & Johnson
Kyorin Pharmaceutical
Mabion
Mesoblast
Neovacs
Oncobiologics
Oncodesign
Pfenex
Pfizer
Qu Biologics
Receptos
Sandoz International
Selexys Pharmaceuticals
Takeda Pharmaceutical Company
Teva Pharmaceutical Industries
Virobay
Winston Pharmaceuticals
For more information visit .researchandmarkets.com/research/l6pzmr/crohns_disease
Wednesday, September 2, 2015
. Buy Bronchial online Buy Naprosyn (Naproxen) without Rx DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/jnsg6k/acute_heart)
has announced the addition of the "Acute
Heart Failure - Pipeline Review, H2 2015" report to their
offering.
This report provides comprehensive information on the therapeutic
development for Acute Heart Failure, complete with comparative analysis
at various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. http://doctor-answers.blogspot.com/ About Eumosone Viagra Soft (Sildenafil Citrate) It also
reviews key players involved in the therapeutic development for Acute
Heart Failure and special features on late-stage and discontinued
projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. Nimotop (Nimodipine) with free prescription Buy Chloromycetin (Chloramphenicol) with no Rx It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
Amgen Inc.
Angion Biomedica Corp.
Bayer AG
Lee s Pharmaceutical Holdings Limited
Novartis AG
Nyken BV
Ono Pharmaceutical Co., Ltd.
PhaseBio Pharmaceuticals, Inc.
Trevena, Inc.
Drug Profiles
ANG-4011
BR-5489
cenderitide
istaroxime
NYK-1112
omecamtiv mecarbil
ONO-4232
PB-1046
serelaxin
TRV-027
TRV-120023
ularitide
For more information visit .researchandmarkets.com/research/jnsg6k/acute_heart
Subscribe to:
Posts (Atom)